Literature DB >> 12930754

An N-ethyl-N-nitrosourea mutagenesis screen for epigenetic mutations in the mouse.

Ivona Percec1, Joanne L Thorvaldsen, Robert M Plenge, Christopher J Krapp, Joseph H Nadeau, Huntington F Willard, Marisa S Bartolomei.   

Abstract

The mammalian epigenetic phenomena of X inactivation and genomic imprinting are incompletely understood. X inactivation equalizes X-linked expression between males and females by silencing genes on one X chromosome during female embryogenesis. Genomic imprinting functionally distinguishes the parental genomes, resulting in parent-specific monoallelic expression of particular genes. N-ethyl-N-nitrosourea (ENU) mutagenesis was used in the mouse to screen for mutations in novel factors involved in X inactivation. Previously, we reported mutant pedigrees identified through this screen that segregate aberrant X-inactivation phenotypes and we mapped the mutation in one pedigree to chromosome 15. We now have mapped two additional mutations to the distal chromosome 5 and the proximal chromosome 10 in a second pedigree and show that each of the mutations is sufficient to induce the mutant phenotype. We further show that the roles of these factors are specific to embryonic X inactivation as neither genomic imprinting of multiple genes nor imprinted X inactivation is perturbed. Finally, we used mice bearing selected X-linked alleles that regulate X chromosome choice to demonstrate that the phenotypes of all three mutations are consistent with models in which the mutations have affected molecules involved specifically in the choice or the initiation of X inactivation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930754      PMCID: PMC1462673     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  55 in total

1.  Targeted mutagenesis of Tsix leads to nonrandom X inactivation.

Authors:  J T Lee; N Lu
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

Review 2.  Forty years of decoding the silence in X-chromosome inactivation.

Authors:  R M Boumil; J T Lee
Journal:  Hum Mol Genet       Date:  2001-10-01       Impact factor: 6.150

Review 3.  Epigenetic reprogramming in mammalian development.

Authors:  W Reik; W Dean; J Walter
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

4.  Imprinting and the epigenetic asymmetry between parental genomes.

Authors:  A C Ferguson-Smith; M A Surani
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

5.  Mammalian X-chromosome action: inactivation limited in spread and region of origin.

Authors:  L B RUSSELL
Journal:  Science       Date:  1963-05-31       Impact factor: 47.728

6.  Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation.

Authors:  E Heard; C Rougeulle; D Arnaud; P Avner; C D Allis; D L Spector
Journal:  Cell       Date:  2001-12-14       Impact factor: 41.582

Review 7.  Imprinted X inactivation in eutherians: a model of gametic execution and zygotic relaxation.

Authors:  K D Huynh; J T Lee
Journal:  Curr Opin Cell Biol       Date:  2001-12       Impact factor: 8.382

8.  Imprinting of a RING zinc-finger encoding gene in the mouse chromosome region homologous to the Prader-Willi syndrome genetic region.

Authors:  M T Jong; A H Carey; K A Caldwell; M H Lau; M A Handel; D J Driscoll; C L Stewart; E M Rinchik; R D Nicholls
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

Review 9.  Mouse ENU mutagenesis.

Authors:  M J Justice; J K Noveroske; J S Weber; B Zheng; A Bradley
Journal:  Hum Mol Genet       Date:  1999       Impact factor: 6.150

10.  Gene action in the X-chromosome of the mouse (Mus musculus L.).

Authors:  M F LYON
Journal:  Nature       Date:  1961-04-22       Impact factor: 49.962

View more
  9 in total

1.  Genetic and parent-of-origin influences on X chromosome choice in Xce heterozygous mice.

Authors:  Lisa Helbling Chadwick; Huntington F Willard
Journal:  Mamm Genome       Date:  2005-10-20       Impact factor: 2.957

Review 2.  N-ethyl-N-nitrosourea mutagenesis: boarding the mouse mutant express.

Authors:  Sabine P Cordes
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

3.  Genetic control of X chromosome inactivation in mice: definition of the Xce candidate interval.

Authors:  Lisa Helbling Chadwick; Lisa M Pertz; Karl W Broman; Marisa S Bartolomei; Huntington F Willard
Journal:  Genetics       Date:  2006-04-02       Impact factor: 4.562

4.  Nonrandom X chromosome inactivation is influenced by multiple regions on the murine X chromosome.

Authors:  Joanne L Thorvaldsen; Christopher Krapp; Huntington F Willard; Marisa S Bartolomei
Journal:  Genetics       Date:  2012-08-10       Impact factor: 4.562

5.  An N-ethyl-N-nitrosourea mutagenesis recessive screen identifies two candidate regions for murine cardiomyopathy that map to chromosomes 1 and 15.

Authors:  Liliana Fernandez; Douglas A Marchuk; Jennifer L Moran; David R Beier; Howard A Rockman
Journal:  Mamm Genome       Date:  2009-04-23       Impact factor: 2.957

Review 6.  The use of mouse models to study epigenetics.

Authors:  Marnie Blewitt; Emma Whitelaw
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

7.  Embryonic loss of human females with partial trisomy 19 identifies region critical for the single active X.

Authors:  Barbara R Migeon; Michael A Beer; Hans T Bjornsson
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

8.  Genetic architecture of skewed X inactivation in the laboratory mouse.

Authors:  John D Calaway; Alan B Lenarcic; John P Didion; Jeremy R Wang; Jeremy B Searle; Leonard McMillan; William Valdar; Fernando Pardo-Manuel de Villena
Journal:  PLoS Genet       Date:  2013-10-03       Impact factor: 5.917

9.  Mouse models of human ocular disease for translational research.

Authors:  Mark P Krebs; Gayle B Collin; Wanda L Hicks; Minzhong Yu; Jeremy R Charette; Lan Ying Shi; Jieping Wang; Jürgen K Naggert; Neal S Peachey; Patsy M Nishina
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.